Your browser doesn't support javascript.
loading
Ticagrelor versus placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: Rationale and design of a randomized, double-blind, parallel-group, multicenter phase 3 study (HESTIA3).
Heeney, Matthew M; Abboud, Miguel R; Amilon, Carl; Andersson, Marielle; Githanga, Jessie; Inusa, Baba; Kanter, Julie; Leonsson-Zachrisson, Maria; Michelson, Alan D; Berggren, Anders R.
Afiliação
  • Heeney MM; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, 300 Longwood Ave, Boston, MA 02115, USA. Electronic address: matthew.heeney@childrens.harvard.edu.
  • Abboud MR; American University of Beirut Medical Center, Cairo Street, Beirut, Lebanon. Electronic address: ma56@aub.edu.lb.
  • Amilon C; BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Pepparedsleden 1, Mölndal 431 83, Sweden. Electronic address: carl.amilon@astrazeneca.com.
  • Andersson M; BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Pepparedsleden 1, Mölndal 431 83, Sweden. Electronic address: Marielle.Andersson@astrazeneca.com.
  • Githanga J; Hematology and Blood Transfusion Unit, Department of Human Pathology, University of Nairobi, P. O. Box 19676, Nairobi 00202, Kenya. Electronic address: jessie.githanga@uonbi.ac.ke.
  • Inusa B; Paediatric Hematology, Guy's and St Thomas' NHS Trust, Evelina London Children's Hospital, Westminster Bridge Rd, Lambeth, London SE1 7EH, UK. Electronic address: Baba.Inusa@gstt.nhs.uk.
  • Kanter J; Hematology-Oncology, Department of Medicine, University of Alabama at Birmingham, 2000 6th Avenue S, Birmingham, AL 35233, USA. Electronic address: kanter@musc.edu.
  • Leonsson-Zachrisson M; BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Pepparedsleden 1, Mölndal 431 83, Sweden. Electronic address: Maria.Leonsson-Zachrisson@astrazeneca.com.
  • Michelson AD; Center for Platelet Research Studies, Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, 300 Longwood Avenue, Karp 08213, Boston, MA 02115, USA. Electronic address: Alan.Michelson@childrens.harvard.edu.
  • Berggren AR; BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Pepparedsleden 1, Mölndal 431 83, Sweden. Electronic address: anders.r.berggren@astrazeneca.com.
Contemp Clin Trials ; 85: 105835, 2019 10.
Article em En | MEDLINE | ID: mdl-31446143
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores da Agregação Plaquetária / Ticagrelor / Anemia Falciforme Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores da Agregação Plaquetária / Ticagrelor / Anemia Falciforme Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article